Predicting the Premenstrual Syndrome Based on Alexithymia and Self-Efficacy in Women with Migraine: A Cross-Sectional Study

Document Type : Short communication

Authors

1 Department of Consulting, Faculty of Literature and Humanities, University of Guilan, Rasht, Iran

2 Department of Psychology, Rasht Branch, Islamic Azad University, Rasht, Iran

3 Neuroscience Research Center, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran

Abstract

Abstract
Background: Premenstrual Syndrome (PMS) is a common problem in women with migraines. Due to the importance of recognizing aspects of this issue, this study was conducted to investigate the role of alexithymia and self-efficacy factors in predicting PMS.
Methods: This analytical cross-sectional study was performed on the statistical population of women with migraine referred to medical centers in Rasht in 2021. 160 women with migraines participated in convenience sampling methods from medical centers and responded to the Demographic Information Questionnaire, Premenstrual Symptoms Screening Tool (PSST), Toronto Alexithymia Scale (TAS-20) and General Self-Efficacy Scale (GSE). Data analysis was performed using IBM SPSS 21 (IBM Inc, New York, USA) statistical software.
Results: The results showed that 59.6% of the women had PMS. Pearson correlation coefficient showed that PMS was negatively associated with self-efficacy (r=-0.28; p=0.001) and positively associated with alexithymia (r=0.22; P=0.001). Multiple linear regression analysis indicated that the self-efficacy variable (β=-0.27) negatively predicts 11% of the changes in the PMS variable.
Conclusion: Self-efficacy and alexithymia are PMS-related factors; thus it is suggested that health care providers pay attention to the importance of these psychological factors in developing treatment plans.

Keywords


Abstract
Background: Premenstrual Syndrome (PMS) is a common problem in women with migraines. Due to the importance of recognizing aspects of this issue, this study was conducted to investigate the role of alexithymia and self-efficacy factors in predicting PMS.
Methods: This analytical cross-sectional study was performed on the statistical population of women with migraine referred to medical centers in Rasht in 2021. 160 women with migraines participated in convenience sampling methods from medical centers and responded to the Demographic Information Questionnaire, Premenstrual Symptoms Screening Tool (PSST), Toronto Alexithymia Scale (TAS-20) and General Self-Efficacy Scale (GSE). Data analysis was performed using IBM SPSS 21 (IBM Inc, New York, USA) statistical software.
Results: The results showed that 59.6% of the women had PMS. Pearson correlation coefficient showed that PMS was negatively associated with self-efficacy (r=-0.28; p=0.001) and positively associated with alexithymia (r=0.22; P=0.001). Multiple linear regression analysis indicated that the self-efficacy variable (β=-0.27) negatively predicts 11% of the changes in the PMS variable.
Conclusion: Self-efficacy and alexithymia are PMS-related factors; thus it is suggested that health care providers pay attention to the importance of these psychological factors in developing treatment plans.
Keywords: Alexithymia, Female, Migraine disorders, Premenstrual syndrome, Self-Efficacy 

Introduction 
Migraines are more common in men than women in the pre-adolescent years, but become more common in women as puberty begins, and in late adolescence, women suffer from migraines approximately twice as often as men. The prevalence of migraine is also between 25 and 55 years (1).  Epidemiological studies show that approximately 33 to 64% of women with migraine suffer from Premenstrual Syndrome (PMS), the difference between this statistic is in controlling or not controlling Menstrual Migraine (MM) in women with migraine (2). PMS is characterized by a wide range of mood, physical, and behavioral symptoms that occur in the luteal phase of the menstrual cycle and disappear after the onset of the menstrual bleeding. As a physical disease, this syndrome is in the tenth edition of the International Classification of Diseases (ICD-10) (3). 
Although the role of biological factors and hormones is prominent in the etiology of PMS, studies have shown that psychological and social factors are also effective. In fact, it can be stated that the etiology of PMS can be explained based on the biopsychosocial model (2). Recent studies have also indicated that psychological factors such as stress (4), difficulties in emotion regulation (5) and personality traits (6) are among the factors affecting PMS. Alexithymia has been reported in some studies as an effective factor in PMS (7,8). Some studies also indicate a high frequency of alexithymia in women with migraines (9); but there is also contradictory research (10). Alexithymia can be defined as difficulty in identifying and describing emotions and externally-oriented thinking (11). 
Self-efficacy is another psychological factor whose role on PMS is unclear, as one study showed that women with PMS have high self-efficacy (12). A negative relationship between PMS and coping self-efficacy was reported in another study (13). However, there is strong evidence in the history that self-efficacy in women with migraines is lower than in the normal population (14). 
Studies have shown that psychological factors can play an important role in PMS, but studies on the role of self-efficacy and alexithymia have conflicting results; accordingly, it is necessary to obtain stronger evidence through repeated studies. Understanding the psychological factors affecting PMS can play a significant role in developing treatment plans for people with PMS. Therefore, the aim of this study was to predict PMS based on alexithymia and self-efficacy in women with migraine.

Materials and Methods
Study participants and setting
 This analytical cross-sectional study was conducted in the statistical population of women with migraine referred to medical centers in Rasht in 2021. Based on the dispersion of Premenstrual Symptoms Screening Tool (PSST) in the study of Maddineshat et al (15) (ϭ = 4.55, 1-α = 0.05; 1-β =0.90; d = 1.27) and the formula of Chow et al (16), at least the sample size was 135 people. The sample size was increased to 160 people to prevent possible falls. Women with migraine in a convenient sampling method participated in this study from medical centers in Rasht (e.g. Guilan Pain Clinic, Dr. Kashiri Clinic, Imam Reza Clinic and Poursina Hospital) from February 23 to August 6, 2021. Inclusion criteria were as follows: diagnosis of migraine headache by a neurologist, age range 18 to 50 years and having at least a diploma. Exclusion criteria included: head trauma experience, lack of informed consent, alcohol or drug addiction and having physical and psychiatric disorders (based on the participants’ statements).
The following tools were utilized to collect data: demographic information questionnaire, Premenstrual Symptoms Screening Tool (PSST) (17), Toronto Alexithymia Scale (TAS-20) (18) and General Self-Efficacy Scale (GSE) (19) which had standard validity and reliability. Data were collected from the mentioned medical centers and after explaining the objectives of the research and receiving the informed consent, the research tools were provided to the patients and they were asked to respond in 20 minutes. 
Participation in this study was voluntary and participants responded to the tools with full knowledge of the research objectives. This study was approved by the Ethics Committee of Islamic Azad University, Rasht branch (Ethics code: IR.IAU.RASHT.REC.1400.005).
Data analysis was performed using IBM SPSS 21 (IBM Inc, New York, USA) statistical software. Qualitative data were reported utilizing frequency and percentage indices, and quantitative data were reported using mean and standard deviation indices. The normality of data distribution was assessed with the help of the Kolmogorov-Smirnov test. In the analysis section, Pearson correlation coefficient and multiple regression tests with multiple enter method were used.

Results
160 questionnaires were administered but 156 questionnaires were complete and could be analyzed; demographic information of the participants is presented in table 1. 

Table 1. Demographic information of the participants (n = 156)

Variables

M±SD

(Range) / No.(%)

Age (years)

33.23±8.71 (18-50)

PSST

33.27±8.10 (7-57)

GSE

27.40±5.64 (15-40)

TAS-20

58.30±11.46 (29-88)

With PMS

93 (59.6)

Without PMS

63 (40.4)

Marital status

Single

64 (41.0)

Married

83 (53.2)

divorced

8 (5.1)

Death

1 (0.6)

Education level

Diploma and

35 (22.4)

Associate and Bachelor

84 (53.8)

Postgraduate education

37 (23.7)

Employment status

Unemployed

22 (14.1)

Student

41 (26.3)

Government job

41 (26.3)

Retired

5 (3.2)

Freelancer

47 (30.1)

Number of children

Zero

83 (53.2)

One

35 (22.4)

Two

32 (20.5)

Three

5 (3.2)

Four

1 (0.6)

Note: M=Mean; SD= Std. Deviation; PSST=Premenstrual Symptoms Screening Tool; GSE= General Self-Efficacy Scale; TAS-20=Toronto Alexithymia Scale;  PMS= Premenstrual Syndrome.

The mean and standard deviation of the participants’ age was 33.23 ± 8.71 years. The results showed that 93 women (59.6%) had PMS. Also, the scores of the research variables were in the normal distribution (p<0.05). Pearson correlation coefficient indicated that PMS was negatively associated with self-efficacy (r=-0.28; p=0.001) and positively associated with alexithymia (r=0.22; p=0.001). To determine the role of self-efficacy and alexithymia variables in predicting PMS, a summary of multiple regression was utilized in a simultaneous enter method. The results showed that the Durbin Watson Test (1.98) is between 1.50 and 2.50, indicating a lack of autocorrelation, as well as the VIF for the predictor variables of 1.07.
 A tolerance of 0.59 was calculated, indicating that there is no multicollinearity relationship between the variables. Regression results showed that the self-efficacy variable negatively with the path coefficient (β=-0.27) can predict PMS, but the role of alexithymia in the regression model was not significant. A total of 11% of the variables of PMS in migraine patients can be explained based on this regression model.

Discussion 
The present study aimed to predict PMS based on alexithymia and self-efficacy in women with migraine in an analytical cross-sectional study. It was shown that 59.6% of women with migraine suffer from PMS. In this regard, the present result is consistent with the studies conducted by Vetvik et al (20) and Vetvik et al (21). The results of previous studies indicate that over 50% of women with migraines experience PMS. 
 Other results showed that self-efficacy was negatively related to alexithymia and positively associated with PMS, but only self-efficacy was able to predict PMS. Previous studies by Alpaslan et al (7) and De Berardis et al (8) also reported that alexithymia was higher in women with PMS. Studies show that alexithymia is present in a wide range of psychological and physical disorders (22); therefore, it is concluded that cognitive deficits in emotion processing play an effective role in predicting physical and psychological disorders, but more studies are required to be conducted to clarify the role of alexithymia in PMS pathogenesis. Self-efficacy plays an important role in regulating emotions. It also allows people to interpret potentially threatening expectations as manageable challenges and helps them perceive less stress in such situations. Thus, by reducing negative thoughts and potential threats, individuals can regulate their emotional states. In fact, self-efficacy can be considered a protective factor against pressures and life threats (23). This study is important since it was performed in a large sample of women with migraine and considered the role of psychological factors (self-efficacy and alexithymia) in predicting PMS. 
As previously mentioned in the etiology of PMS to the biopsychosocial model, it can be stated that PMS is a disorder with multifaceted etiology. It was shown in previous studies that hormonal changes, economic problems, urban growth, lack of menstrual education programs, increase stress and other psychological factors are involved in PMS (2,4). In this study, the role of two important psychological factors was specifically examined since there was conflicting evidence in this regard. Therefore, other aspects of etiology need to be considered in future studies. However, for this cross-sectional study, focus on migraine types, failure to collect data randomly, use of self-reported questionnaires and lack of causation were some of the limitations that should be interpreted in the results. This study was performed on women with migraines and due to the lack of a control group, the results could not be generalized to the general population. Also, the lack of precise control of confounding variables, using valid tools is another limitation of this research. Please note these limitations in generalizing the results.

Conclusion
 The results of this study showed that over 50% of women with migraines suffer from PMS. Self-efficacy and alexithymia are two effective psychological factors of PMS, and more studies are required to better understand their relationship. However, in order to reduce bias in future studies, other psychological and biological factors should be considered in elucidating premenstrual syndrome which was not considered in this study. But it is suggested that attention should be paid in the therapeutic interventions of people with migraine to reduce PMS to improve self-efficacy and reduce alexithymia.

Acknowledgements
Here, we would like to thank the clinics of Rasht and the people who participated in this research.

Conflict of Interest
The authors declared no conflicts of interest.

Funding
No governmental or non-governmental organizations have supported this study.

  1. Lipton RB, Bigal ME. Migraine: epidemiology, impact, and risk factors for progression. Headache 2005 Apr;45 Suppl 1:S3-S13. https://pubmed.ncbi.nlm.nih.gov/15833088/
  2. Zendehdel M, Elyasi F. Biopsychosocial etiology of premenstrual syndrome: a narrative review. J Family Med Prim Care 2018 Mar-Apr;7(2):346-356. https://pubmed.ncbi.nlm.nih.gov/30090776/
  3. Zhang Y, Kong Q, Chen J, Li L, Wang D, Zhou J. International classification of headache disorders 3rd edition beta-based field testing of vestibular migraine in China: demographic, clinical characteristics, audiometric findings and diagnosis statues. Cephalalgia 2016 Mar;36(3):240-8. https://pubmed.ncbi.nlm.nih.gov/25986149/
  4. Zarei Z, Bazzazian S. The relationship between premenstrual syndrome disorder, stress and quality of life in female students. Iran J Psychiatr Nurs 2015 Feb 10;2(4):49-58.
  5. Eggert L, Witthöft M, Hiller W, Kleinstäuber M. Emotion regulation in women with premenstrual syndrome (PMS): explicit and implicit assessments. Cognitive Ther Res 2016 Dec;40(6):747-63.
  6. Erenoğlu R, Sözbir ŞY. Are premenstrual syndrome and dysmenorrhea related to the personality structure of women? A descriptive relation-seeker type study. Perspect Psychiatr Care 2020 Oct;56(4):979-84. https://pubmed.ncbi.nlm.nih.gov/32488914/
  7. Alpaslan AH, Avcı K, Soylu N, Taş HU. Association between premenstrual syndrome and alexithymia among Turkish University students. Gynecol Endocrinol 2014 May;30(5):377-80. https://pubmed.ncbi.nlm.nih.gov/24512608/
  8. De Berardis D, Campanella D, Gambi F, Sepede G, Carano A, Pelusi L, et al. Alexithymia and body image disturbances in women with premenstrual dysphoric disorder. J Psychosom Obstet Gynaecol 2005 Dec;26(4):257-64. https://pubmed.ncbi.nlm.nih.gov/16457421/
  9. Zebardast A, Shafieetabar M. Positive/negative affect, strategies of cognitive emotion regulation and alexithymia in female patients with migraine headache. J Child Ment Health 2019 Jul 10;6(2):180-93.
  10. Dikmen PY, Aysevener EO, Kosak S, Aydınlar EI, Kocaman AS. Relationship between MIDAS, depression, anxiety and alexithymia in migraine patients. Acta Neurol Belg 2020 Aug;120(4):837-44. https://pubmed.ncbi.nlm.nih.gov/29147944/
  11. Rieffe C, Oosterveld P, Terwogt MM. An alexithymia questionnaire for children: Factorial and concurrent validation results. Personality Individual Differences 2006 Jan 1;40(1):123-33.
  12. Telek T, Gonda X, Lazary J, Benko A, Pap D, Vargha A, et al. The possible protective role of personality dimensions against premenstrual syndrome. Psychiatry Res 2010 Aug 30;179(1):81-5. https://pubmed.ncbi.nlm.nih.gov/20472306/
  13. Lee Y, Im EO. A path analysis of stress and premenstrual symptoms in Korean international and Korean domestic students. J Adv Nurs 2016 Dec;72(12):3045-3059. https://pubmed.ncbi.nlm.nih.gov/27377582/
  14. Seng EK, Holroyd KA. Dynamics of changes in self-efficacy and locus of control expectancies in the behavioral and drug treatment of severe migraine. Ann Behav Med 2010 Dec;40(3):235-47. https://pubmed.ncbi.nlm.nih.gov/20812037/
  15. Maddineshat M, Keyvanloo S, Lashkardoost H, Arki M, Tabatabaeichehr M. Effectiveness of Group Cognitive-Behavioral Therapy on Symptoms of Premenstrual Syndrome (PMS)‎. Iran J Psychiatry 2016 Jan;11(1):30-6. https://pubmed.ncbi.nlm.nih.gov/27252766/
  16. Chow SC, Shao J, Wang H, Lokhnygina Y. Sample size calculations in clinical research. 3rd ed. New York: Taylor & Francis Group Chapman and Hall/CRC; 2017. 52 p.
  17. Steiner M, Macdougall M, Brown E. The premenstrual symptoms screening tool (PSST) for clinicians. Arch Womens Ment Health 2003 Aug;6(3):203-9. https://pubmed.ncbi.nlm.nih.gov/12920618/
  18. Bagby RM, Parker JD, Taylor GJ. The twenty-item Toronto alexithymia scale—I. item selection and cross-validation of the factor structure. J Psychosom Res 1994 Jan;38(1):23-32. https://pubmed.ncbi.nlm.nih.gov/8126686/
  19. Schwarzer R, Hallum S. Perceived teacher self-efficacy as a predictor of job stress and burnout: Mediation analyses. Applied Psychology 2008;57:152-71.
  20. Vetvik KG, MacGregor EA, Lundqvist C, Russell MB. Symptoms of premenstrual syndrome in female migraineurs with and without menstrual migraine. J Headache Pain 2018 Oct 17;19(1):97. https://pubmed.ncbi.nlm.nih.gov/30332985/
  21. Vetvik KG, MacGregor EA, Lundqvist C, Russell MB. Prevalence of menstrual migraine: a population-based study. Cephalalgia 2014 Apr;34(4):280-8. https://pubmed.ncbi.nlm.nih.gov/24101732/
  22. Güleç MY, Altintaş M, İnanç L, Bezgin ÇH, Koca EK, Güleç H. Effects of childhood trauma on somatization in major depressive disorder: the role of alexithymia. J Affect Disord 2013 Mar 20;146(1):137-41. https://pubmed.ncbi.nlm.nih.gov/22884234/
  23. Bandura A. Self-efficacy: the exercise of control. 4th ed. New York, NY: W.H. Freeman; 1997. 604 p.